ArticleHepatology communications2022

Favorable impact of long-term SGLT2 inhibitor for NAFLD complicated by diabetes mellitus: A 5-year follow-up study.

Norio Akuta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.